---
title: "GRANT JEREMY T — Ownership Dossier"
canonical: https://whiteintel.dev/entity/8a075743-e14d-5d4e-89d2-7a2059f99036
json: https://whiteintel.dev/api/public/dossier/8a075743-e14d-5d4e-89d2-7a2059f99036
identifier: sec:0002004368
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GRANT JEREMY T

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0002004368`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/8a075743-e14d-5d4e-89d2-7a2059f99036  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/8a075743-e14d-5d4e-89d2-7a2059f99036  

## Ownership & control

### Holdings / subsidiaries

- **Theravance Biopharma, Inc.** (director) — https://whiteintel.dev/entity/d7255ed9-d961-59e3-906e-8f659740f843

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GRANT JEREMY T**. Human view: https://whiteintel.dev/entity/8a075743-e14d-5d4e-89d2-7a2059f99036 · Structured JSON: https://whiteintel.dev/api/public/dossier/8a075743-e14d-5d4e-89d2-7a2059f99036._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._